← Open Payments lookup

CESAR MATOS-MARTINEZ: Open Payments

NPI 1639240575 · EDINBURG, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,551 in 98 payments from 11 companies in 2025. Trend: 2023 $202 · 2024 $692 · 2025 $1,551

Food & beverage: $1,551
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)10$243
Otsuka America Pharmaceutical, Inc.15$227
Lundbeck LLC10$221
Teva Pharmaceuticals USA, Inc.10$186
Alkermes, Inc.14$159
ABBVIE INC.15$155
E.R. Squibb & Sons, L.L.C.14$144
Janssen Pharmaceuticals, Inc3$77
Axsome Therapeutics, Inc.3$59
Takeda Pharmaceuticals U.S.A., Inc.3$55

Products named: REXULTI, CAPLYTA, ARISTADA, VRAYLAR, COBENFY, AUSTEDO XR, UZEDY, Auvelity.

Industry payments across TX — which companies pay providers there.